Mayne Pharma Group (ASX:MYX) Ending Cash Position : A$53.7 Mil (As of Dec. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Mayne Pharma Group Ending Cash Position?

Mayne Pharma Group's Ending Cash Position for the quarter that ended in Dec. 2024 was A$53.7 Mil.

Mayne Pharma Group's quarterly Ending Cash Position increased from Dec. 2023 (A$109.2 Mil) to Jun. 2024 (A$110.1 Mil) but then declined from Jun. 2024 (A$110.1 Mil) to Dec. 2024 (A$53.7 Mil).

Mayne Pharma Group's annual Ending Cash Position declined from Jun. 2022 (A$96.7 Mil) to Jun. 2023 (A$92.6 Mil) but then increased from Jun. 2023 (A$92.6 Mil) to Jun. 2024 (A$110.1 Mil).

Mayne Pharma Group Ending Cash Position Historical Data

The historical data trend for Mayne Pharma Group's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mayne Pharma Group Ending Cash Position Chart

Mayne Pharma Group Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Ending Cash Position

Get a 7-Day Free Trial

137.79

97.98

96.67

92.62

110.07

Mayne Pharma Group Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Ending Cash Position	Get a 7-Day Free Trial															175.54	92.62	109.23	110.07	53.71

Mayne Pharma Group Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Mayne Pharma Group's Ending Cash Position for the fiscal year that ended in Jun. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	92.616	+	17.452
	=	110.1

Mayne Pharma Group's Ending Cash Position for the quarter that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	110.068	+	-56.358
	=	53.7

Mayne Pharma Group Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Mayne Pharma Group's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Mayne Pharma Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mayne Pharma Group Ltd (ASX:MYX) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

MAYNF:USA HG6:Germany

Address

1538 Main North Road, Salisbury South, Salisbury, SA, AUS, 5106

Website

http://www.maynepharma.com

Mayne Pharma Group Ltd is a specialty pharmaceutical company focused on commercializing novel and generic pharmaceuticals It has a Forty-year track record of innovation and success in developing oral drug delivery systems. The Company's Business consists of three operating segments being International, Women's Health and Dermatology. The Dermatologysegment distributes dermatology products (branded and generic) in the U.S. on a portfolio basis, The Women's Health segment distributes branded women's health products in the U.S. International's segment revenue and gross profit are derived principally from the Australian manufacture and sale of branded and generic pharmaceutical products.